Carregant...
Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma
SIMPLE SUMMARY: Novel approaches to target RAS-signaling have led to the so called “RAS renaissance”. In HCC, it was demonstrated that wild-type RAS-RAF-ERK-signaling strongly contributes to HCC progression and drug resistance. In this context, microRNA-622 has emerged as one of the most promising t...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967205/ https://ncbi.nlm.nih.gov/pubmed/33803354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051183 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|